The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.0M data for 1.3M Compounds and 9.6K Targets. Of those, 1.5M data for 695K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Advanced Search

20 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Identification and characterization of a prostaglandin transporter.EBI
Albert Einstein College of Medicine
Estradiol 17 beta-D-glucuronide is a high-affinity substrate for oatp organic anion transporter.EBI
Albert Einstein College of Medicine
Cloning of mouse prostaglandin transporter PGT cDNA: species-specific substrate affinities.EBI
Albert Einstein College of Medicine
Identification of lactate as a driving force for prostanoid transport by prostaglandin transporter PGT.EBI
Albert Einstein College of Medicine
Structural determinants of substrates for the prostaglandin transporter PGT.EBI
Albert Einstein College of Medicine
Enzymatic transition states and dynamic motion in barrier crossing.EBI
Albert Einstein College of Medicine
Synthesis of novel ketoconazole derivatives as inhibitors of the human Pregnane X Receptor (PXR; NR1I2; also termed SXR, PAR).EBI
Albert Einstein College of Medicine
Selective Inhibitors of Helicobacter pylori Methylthioadenosine Nucleosidase and Human Methylthioadenosine Phosphorylase.EBI
Albert Einstein College of Medicine
Current Insights of BRAF Inhibitors in Cancer.EBI
Albert Einstein College of Medicine
Uracil derivatives as AXL and c-MET kinase inhibitorsBDB
Ignyta
Azetidine derivativesBDB
Boehringer Ingelheim International
Buprenophine analogsBDB
Purdue Pharma
Heterocyclic compound and use thereofBDB
Takeda Pharmaceutical
RNase H active site inhibitors of human immunodeficiency virus type 1 reverse transcriptase: design, biochemical activity, and structural information.BDB
Gilead Sciences
Structural requirements for factor Xa inhibition by 3-oxybenzamides with neutral P1 substituents: combining X-ray crystallography, 3D-QSAR, and tailored scoring functions.BDB
Aventis Pharma Deutschland